219 related articles for article (PubMed ID: 16126934)
1. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
2. [CT imaging of COPD--importance of phenotyping (emphysema dominant and airway disorder dominant)].
Mishima M
Nihon Rinsho; 2007 Apr; 65(4):648-54. PubMed ID: 17419383
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China.
Zhou M; Huang SG; Wan HY; Li B; Deng WW; Li M
Chin Med J (Engl); 2004 Oct; 117(10):1481-4. PubMed ID: 15498369
[TBL] [Abstract][Full Text] [Related]
4. Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.
Bchir S; Nasr HB; Hakim IR; Anes AB; Yacoub S; Garrouch A; Benzarti M; Bauvois B; Tabka Z; Chahed K
Mol Diagn Ther; 2015 Dec; 19(6):375-87. PubMed ID: 26303146
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema.
Minematsu N; Nakamura H; Tateno H; Nakajima T; Yamaguchi K
Biochem Biophys Res Commun; 2001 Nov; 289(1):116-9. PubMed ID: 11708786
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.
Haq I; Lowrey GE; Kalsheker N; Johnson SR
Thorax; 2011 Nov; 66(11):970-6. PubMed ID: 21730350
[TBL] [Abstract][Full Text] [Related]
7. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
[TBL] [Abstract][Full Text] [Related]
8. Gene-environment interaction between the MMP9 C-1562T promoter variant and cigarette smoke in the pathogenesis of chronic obstructive pulmonary disease.
Stankovic M; Kojic S; Djordjevic V; Tomovic A; Nagorni-Obradovic L; Petrovic-Stanojevic N; Mitic-Milikic M; Radojkovic D
Environ Mol Mutagen; 2016 Jul; 57(6):447-54. PubMed ID: 27270564
[TBL] [Abstract][Full Text] [Related]
9. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
[TBL] [Abstract][Full Text] [Related]
11. Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele.
Ito I; Nagai S; Hoshino Y; Muro S; Hirai T; Tsukino M; Mishima M
Chest; 2004 Jan; 125(1):63-70. PubMed ID: 14718422
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism in matrix metalloproteinase-9 and transforming growth factor-β1 and susceptibility to combined pulmonary fibrosis and emphysema in a Chinese population.
Xu L; Bian W; Gu XH; Shen C
Kaohsiung J Med Sci; 2017 Mar; 33(3):124-129. PubMed ID: 28254114
[TBL] [Abstract][Full Text] [Related]
13. MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population.
Bchir S; Nasr HB; Anes AB; Benzarti M; Garrouch A; Tabka Z; Chahed K
Mol Diagn Ther; 2016 Dec; 20(6):579-590. PubMed ID: 27412345
[TBL] [Abstract][Full Text] [Related]
14. Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography.
Tsushima K; Sone S; Fujimoto K; Kubo K; Morita S; Takegami M; Fukuhara S
COPD; 2010 Apr; 7(2):117-25. PubMed ID: 20397812
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer.
Rahimi Z; Yari K; Rahimi Z
Asian Pac J Cancer Prev; 2015; 16(3):1175-9. PubMed ID: 25735351
[TBL] [Abstract][Full Text] [Related]
16. Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD.
Sakao S; Tatsumi K; Igari H; Watanabe R; Shino Y; Shirasawa H; Kuriyama T
Chest; 2002 Aug; 122(2):416-20. PubMed ID: 12171811
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-7 A-181G and its interaction with matrix metalloproteinase-9 C-1562T polymorphism in preeclamptic patients: association with malondialdehyde level and severe preeclampsia.
Rahimi Z; Kazemian L; Malek-Khosravi S; Najafi F; Rahimi Z
Arch Gynecol Obstet; 2015 Jan; 291(1):45-51. PubMed ID: 25063248
[TBL] [Abstract][Full Text] [Related]
18. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.
Dournes G; Laurent F; Coste F; Dromer C; Blanchard E; Picard F; Baldacci F; Montaudon M; Girodet PO; Marthan R; Berger P
Am J Respir Crit Care Med; 2015 Jan; 191(1):63-70. PubMed ID: 25393421
[TBL] [Abstract][Full Text] [Related]
19. Impact of Matrix Metalloproteinase 9 on COPD Development in Polish Patients: Genetic Polymorphism, Protein Level, and Their Relationship with Lung Function.
Gilowska I; Kasper Ł; Bogacz K; Szczegielniak J; Szymasek T; Kasper M; Czerwinski M; Sładek K; Majorczyk E
Biomed Res Int; 2018; 2018():6417415. PubMed ID: 30643813
[TBL] [Abstract][Full Text] [Related]
20. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema.
Lambrechts D; Buysschaert I; Zanen P; Coolen J; Lays N; Cuppens H; Groen HJ; Dewever W; van Klaveren RJ; Verschakelen J; Wijmenga C; Postma DS; Decramer M; Janssens W
Am J Respir Crit Care Med; 2010 Mar; 181(5):486-93. PubMed ID: 20007924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
